Moore Capital Management LP Makes New $23.73 Million Investment in Danaher Corporation $DHR

Moore Capital Management LP purchased a new position in shares of Danaher Corporation (NYSE:DHR) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 103,676 shares of the conglomerate’s stock, valued at approximately $23,734,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Elevated Capital Advisors LLC bought a new stake in shares of Danaher in the 4th quarter valued at $26,000. Hilton Head Capital Partners LLC bought a new stake in shares of Danaher in the 4th quarter valued at $27,000. Clal Insurance Enterprises Holdings Ltd increased its stake in shares of Danaher by 71.6% in the 4th quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after acquiring an additional 53 shares in the last quarter. JPL Wealth Management LLC bought a new stake in shares of Danaher in the 3rd quarter valued at $25,000. Finally, WFA of San Diego LLC bought a new stake in shares of Danaher in the 2nd quarter valued at $26,000. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Down 1.9%

NYSE:DHR opened at $177.85 on Thursday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The firm has a 50-day moving average of $180.26 and a 200-day moving average of $203.59. The company has a market cap of $125.88 billion, a PE ratio of 34.40, a PEG ratio of 2.31 and a beta of 0.81. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.

Danaher (NYSE:DHR) last posted its earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.88 earnings per share. As a group, equities research analysts expect that Danaher Corporation will post 8.45 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. Danaher’s dividend payout ratio is presently 30.95%.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on DHR shares. Piper Sandler started coverage on shares of Danaher in a research note on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price objective for the company. DZ Bank started coverage on shares of Danaher in a research note on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective for the company. Rothschild & Co Redburn set a $205.00 price objective on shares of Danaher in a research note on Friday, April 17th. TD Cowen decreased their price target on shares of Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Finally, Royal Bank Of Canada started coverage on shares of Danaher in a research note on Thursday, May 14th. They set an “outperform” rating and a $200.00 price target for the company. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $233.61.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.